Hemant Kumar
Plus aucun poste en cours
Fortune : 14 900 $ au 31/03/2024
Historique de carrière de Hemant Kumar
Anciens postes connus de Hemant Kumar
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GENPREX, INC. | Chief Tech/Sci/R&D Officer | 27/09/2021 | 01/10/2023 |
| ANAPTYSBIO, INC. | Corporate Officer/Principal | - | - |
Rentschler Biopharma SE
 Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Rentschler Biopharma SE develops and produces pharmaceutical products. Its solutions include bioprocess development, bio manufacturing, associated consulting activities including cell line process, cell culture, aseptic filling, consulting, planning and project management services. The company was founded in 1927 and is headquartered in Laupheim, Germany. | Corporate Officer/Principal | - | - |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Formation de Hemant Kumar
| Jawaharlal Nehru Medical College | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Allemagne | 2 |
| Inde | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| GENPREX, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
Rentschler Biopharma SE
Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Rentschler Biopharma SE develops and produces pharmaceutical products. Its solutions include bioprocess development, bio manufacturing, associated consulting activities including cell line process, cell culture, aseptic filling, consulting, planning and project management services. The company was founded in 1927 and is headquartered in Laupheim, Germany. | Health Technology |
- Bourse
- Insiders
- Hemant Kumar
- Expérience
